Opt-out consent

The neoGASTRIC trial will use an opt-out consent process, designed to be as simple as possible for families. This means that babies meeting the eligibility criteria will be automatically included in the trial unless parents opt-out. Parents will be informed about neoGASTRIC through posters and leaflets on the neonatal units and will have the option to opt-out at any point. This will make it easier for parents to be involved in the research and involve families who might not normally take part in research.

If you don't want your baby to take part in neoGASTRIC, please inform a member of the neonatal team. Your baby will continue to receive the routine care of that unit.